Reviva Pharmaceuticals Holdings Inc (RVPH) Financials

$0.53

$0.05 (9.98%)

As on 28-Sep-2026 10:57EDT

Market cap

$6 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	2,617,553.86	20.20	30.80	39.50	24.31	10.10
Operating Profit (EBIT)	-2,617,553.86	-20.20	-30.80	-39.50	-24.31	-10.10
Other Income	--	--	--	--	--	--
Profit before Tax	-2,445,209.57	-19.85	-29.90	-39.24	-24.32	-8.52
Provision for Tax	2,632.01	0.02	0.02	0.02	0.02	0.01
Profit after Tax (Net Income)	-2,447,841.57	-19.86	-29.92	-39.26	-24.34	-8.52
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-24.34	-8.52

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	15,207,245.00	8.65	0.81	5.72	8.39	28.69
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	0.09	0.81	0.57	0.37
Current Liabilities	5,933,345.00	7.28	14.60	17.18	9.96	2.34
Total Liabilities	27,073,935.00	15.92	15.50	23.70	18.92	31.40

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	--	0.82	0.82	--	403.82	1.72
Current Assets	21,140,590.00	15.10	14.68	23.70	18.92	31.40
Total Assets	42,281,164.79	15.92	15.50	23.70	18.92	31.40
Total Debt*	144,093.00	0.41	0.46	--	--	--
Net Current Assets	15.21	7.83	0.08	6.53	12.88	29.06

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-24.59	-33.54	-28.32	-18.96	-10.67
Cash Flow from Investing Activities	--	--	--	--	--	--
Cash from Financing Activities	--	25.56	23.65	33.17	7.79	31.60
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-185,317.88	-5.48	-12.85	-1.41	-23.81	-11.81
Cash EPS ($)	--	-5.48	-12.85	-1.41	-23.81	-11.81
Adjusted Book Value ($)	--	2.38	0.35	0.20	8.21	39.75
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-6.78	-14.40	-1.01	-18.55	-14.78
Free Cash Flow per Share ($)	--	-6.78	-14.40	-1.01	-18.55	-14.78

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-384.78	-856.11	-556.38	-131.28	-49.91
ROE (%)	-32.19	-419.97	-916.17	-556.38	-131.28	-49.91
ROA (%)	-11.58	-126.42	-152.63	-184.22	-96.72	-42.43
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	80.25	--	22.91	-223.84	-140.55	-315.03
Net Profit Growth (%)	-9,028,619.40	33.60	23.79	-61.31	-185.61	-125.24
EPS Growth (%)	-1,457,843.66	0.57	-8.14	0.94	-1.02	-0.44
Book Value Growth (%)	624,951,409.13	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.05	-0.14	-3.66	-0.18	-0.24
Price / Book Value	0.41	0.12	5.19	25.14	0.52	0.07
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-6.00	0.66	0.29	-3.07	0.59	3.24
Close Price ($)	0.63	5.58	36.20	103.00	85.00	57.80
High Price ($)	17.20	43.40	113.20	185.00	122.00	192.20
Low Price ($)	0.26	5.00	12.00	70.00	10.60	52.20
Market Cap ($ Cr)	6.27	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.05	0.56	--	--	--
Short term debt to equity ratio	0.01	0.05	0.56	--	--	--
Current Ratio	3.56	2.08	1.01	1.38	1.90	13.39
Quick Ratio	3.56	--	--	--	--	--
Interest Coverage	-832.12	--	-3,280.51	-2,333.99	-132.97	-4,185.80

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.